SE435057B - 2-(2-((4-metoxibensoyl)amino)fenyl) etyl-1-(legre alkyl eller bensyl) piperidiniumhalider och forfarande for framstellning av dessa - Google Patents

2-(2-((4-metoxibensoyl)amino)fenyl) etyl-1-(legre alkyl eller bensyl) piperidiniumhalider och forfarande for framstellning av dessa

Info

Publication number
SE435057B
SE435057B SE8205535A SE8205535A SE435057B SE 435057 B SE435057 B SE 435057B SE 8205535 A SE8205535 A SE 8205535A SE 8205535 A SE8205535 A SE 8205535A SE 435057 B SE435057 B SE 435057B
Authority
SE
Sweden
Prior art keywords
phenyl
ethyl
amino
compound
methoxybenzoyl
Prior art date
Application number
SE8205535A
Other languages
English (en)
Swedish (sv)
Other versions
SE8205535D0 (sv
SE8205535L (sv
Inventor
J E Lawson
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8205535D0 publication Critical patent/SE8205535D0/xx
Publication of SE8205535L publication Critical patent/SE8205535L/xx
Publication of SE435057B publication Critical patent/SE435057B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8205535A 1981-01-28 1982-09-28 2-(2-((4-metoxibensoyl)amino)fenyl) etyl-1-(legre alkyl eller bensyl) piperidiniumhalider och forfarande for framstellning av dessa SE435057B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides

Publications (3)

Publication Number Publication Date
SE8205535D0 SE8205535D0 (sv) 1982-09-28
SE8205535L SE8205535L (sv) 1982-09-28
SE435057B true SE435057B (sv) 1984-09-03

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8205535A SE435057B (sv) 1981-01-28 1982-09-28 2-(2-((4-metoxibensoyl)amino)fenyl) etyl-1-(legre alkyl eller bensyl) piperidiniumhalider och forfarande for framstellning av dessa

Country Status (19)

Country Link
US (1) US4321386A (da)
JP (1) JPH0348904B2 (da)
AR (1) AR230266A1 (da)
AT (1) AT378183B (da)
AU (1) AU551523B2 (da)
BE (1) BE891938A (da)
CA (1) CA1184917A (da)
CH (1) CH651021A5 (da)
DE (1) DE3223499T1 (da)
DK (1) DK156649C (da)
FI (1) FI65239C (da)
GB (1) GB2100736B (da)
GR (1) GR74720B (da)
IE (1) IE52420B1 (da)
IT (1) IT1147809B (da)
NL (1) NL8220049A (da)
SE (1) SE435057B (da)
WO (1) WO1982002551A1 (da)
YU (1) YU43063B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176772A1 (en) * 2009-04-09 2012-01-30 Cognition Therapeutics Inc Inhibitors of cognitive decline
ES2547730T3 (es) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
AU2012212219B2 (en) 2011-02-02 2017-03-23 Cognition Therapeutics, Inc. Isolated compounds from turmeric oil and methods of use
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Also Published As

Publication number Publication date
IT1147809B (it) 1986-11-26
AU8148582A (en) 1982-08-16
DK156649B (da) 1989-09-18
DK429382A (da) 1982-09-27
IE52420B1 (en) 1987-10-28
IE820191L (en) 1982-07-28
SE8205535D0 (sv) 1982-09-28
DE3223499C2 (da) 1989-11-23
ATA900782A (de) 1984-11-15
FI822443L (fi) 1982-07-08
CA1184917A (en) 1985-04-02
CH651021A5 (de) 1985-08-30
BE891938A (fr) 1982-07-28
GB2100736A (en) 1983-01-06
YU43063B (en) 1989-02-28
FI65239B (fi) 1983-12-30
AR230266A1 (es) 1984-03-01
SE8205535L (sv) 1982-09-28
WO1982002551A1 (en) 1982-08-05
US4321386A (en) 1982-03-23
YU19782A (en) 1985-04-30
DE3223499T1 (de) 1983-01-13
DK156649C (da) 1990-02-05
IT8247667A0 (it) 1982-01-28
FI65239C (fi) 1984-04-10
GB2100736B (en) 1985-01-30
NL8220049A (nl) 1982-11-01
AT378183B (de) 1985-06-25
JPH0348904B2 (da) 1991-07-25
AU551523B2 (en) 1986-05-01
JPS57502216A (da) 1982-12-16
FI822443A0 (fi) 1982-07-08
GR74720B (da) 1984-07-10

Similar Documents

Publication Publication Date Title
CA2558600C (en) A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
US5110933A (en) Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US8536183B2 (en) 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
US3396224A (en) Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
Thomas et al. Synthesis of acylguanidine analogs: inhibitors of ADP-induced platelet aggregation
SE435057B (sv) 2-(2-((4-metoxibensoyl)amino)fenyl) etyl-1-(legre alkyl eller bensyl) piperidiniumhalider och forfarande for framstellning av dessa
Burke Jr et al. Resolution, absolute configuration, and antiarrhythmic properties of the enantiomers of disopyramide, 4-(diisopropylamino)-2-(2-pyridyl)-2-phenylbutyramide
Leeson et al. Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel
Hodgkinson et al. Formation of complexes between aza derivatives of crown ethers and primary alkylammonium salts. Part 4. Diaza-18-crown-6 derivatives
DE69020868T2 (de) Heterozyklische Verbindungen.
DK166776B1 (da) 2,2,5,5-tetramethyl(pyrrolin eller pyrrolidin)-3-yl-carbonylaminoderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
US2746966A (en) Esters of bis-(nu-substituted-3-hydroxypiperidinium) alkanes
PT92324A (pt) Processo para a preparacao de oxadiaminobutanos substituidos
US2914533A (en) Tertiary-aminoalkyl n-(pyridyl)carbamates and their preparation
JPS6069089A (ja) ジヒドロピリジン−5−ホスホネ−ト誘導体およびその製造法
Lampe et al. Cardiotonic agents. 6. Histamine analogs as potential cardiovascular selective H2 agonists
US3071613A (en) N-(2, 2-dialkoxyethyl)-(halogenated-phenyl) alkylamines
US2746967A (en) Derivatives of bis-(nu-substituted-3-hydroxypiperidinium) alkanes
US2553994A (en) Pyridine therapeutic compounds
US3117127A (en) 3-and 4-acetamidopiperidinium halides
Yoneyama et al. Herbicidal activity of N-(2, 3-epoxypropyl) benzenesulfonamide derivatives
FR2521137A1 (fr) Halogenures de piperidinium quaternaire
Kametani et al. Synthesis of heterocyclic compounds. CCLXXXXV. Syntheses of benzomorphan and related compounds. II. The debenzylation of quaternary ammonium salts with thiophenol
SE435058B (sv) 4-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)-etyl) fenyl) bensamid-n-oxid och forfarande for framstellning av denna
JPS6016414B2 (ja) エナミン類およびその製造方法

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8205535-1

Effective date: 19930810

Format of ref document f/p: F